Relationship between Physical Frailty and Low-Grade Inflammation in Late-Life Depression

Journal of the American Geriatrics Society

Volumn 63, Issue 8, 2015, Pages 1652-1657

  Arts, Matheus H L ^a,b   Collard, Rose M ^c,d   Comijs, Hannie C ^e   Naudé, Petrus J W ^b   Risselada, Roelof ^a   Naarding, Paul ^a,c   Oude Voshaar, Richard C ^b  

^a Department of Old Age Psychiatry ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Pro Persona   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

C reactive protein; depressive disorder; frailty; inflammation; interleukin 6; lipocalin 2; neutrophil gelatinase associated lipocalin

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EXHAUSTION; FEMALE; FRAIL ELDERLY; GAIT; GRIP STRENGTH; HUMAN; INFLAMMATION; LATE LIFE DEPRESSION; LOW GRADE INFLAMMATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; MINI MENTAL STATE EXAMINATION; PHENOTYPE; PHYSICAL ACTIVITY; PHYSICAL DISEASE; PHYSICAL FRAILTY; PHYSICAL PERFORMANCE; PRIMARY MEDICAL CARE; SLOWNESS; SMOKING; WALKING SPEED; WEAKNESS; WEIGHT REDUCTION; BLOOD; COMPLICATION; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; HAND STRENGTH; LIFESTYLE; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHOTOMETRY; PHYSIOLOGY; PROGNOSIS;

ACUTE-PHASE PROTEINS; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DEPRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRAIL ELDERLY; HAND STRENGTH; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIFE STYLE; LIPOCALINS; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEPHELOMETRY AND TURBIDIMETRY; PHENOTYPE; PROGNOSIS; PROTO-ONCOGENE PROTEINS;

EID: 84939573831     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13528     Document Type: Article

References (30)

1. Morley JE, Vellas B, Abellan van Kan G, et al., Frailty consensus: A call to action. J Am Med Dir Assoc 2013; 14: 392-397.
2. Collard RM, Boter H, Schoevers RA, et al., Prevalence of frailty in community-dwelling older persons: A systematic review. J Am Geriatr Soc 2012; 60: 1487-1492.
3. Mezuk B, Edwards L, Lohman M, et al., Depression and frailty in later life: A synthetic review. Int J Geriatr Psychiatry 2012; 27: 879-892.
4. Rockwood K, Mitnitski A,. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med 2011; 27: 17-26.
5. Fried LP, Tangen CM, Walston J, et al., Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 563A: M146-M156.
6. Collard RM, Comijs HC, Naarding P, et al., Physical frailty: Vulnerability of patients suffering from late-life depression. Aging Ment Health 2014; 18: 570-578.
7. Fried LP, Ferrucci L, Darer J, et al., Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59A: 255-263.
8. Verhoeven JE, Révész D, Epel ES, et al., Major depressive disorder and accelerated cellular aging: Results from a large psychiatric cohort study. Mol Psychiatry 2014; 19: 895-901.
9. Révész D, Verhoeven JE, Milaneschi Y, et al., Dysregulated physiological stress systems and accelerated cellular aging. Neurobiol Aging 2014; 35: 1422-1430.
10. De Martinis M, Franceschi C, Monti D, et al., Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 2006; 80: 219-227.
11. Moshage H,. Cytokines and the hepatic acute phase response. J Pathol 1997; 181: 257-266.
12. Bremmer MA, Beekman AT, Deeg DJ, et al., Inflammatory markers in late-life depression: Results from a population-based study. J Affect Disord 2008; 6: 249-255.
13. Choi J, Lee HW, Suk K,. Increased plasma levels of lipocalin2 in mild cognitive impairment. J Neurol Sci 2011; 305: 28-33.
14. Naudé PJ, Eisel UL, Comijs HC,. Neutrophil gelatinase-associated lipocalin: A novel inflammatory marker associated with late-life depression. J Psychosom Res 2013; 75: 444-450.
15. Milaneschi Y, Corsi AM, Penninx BW, et al., Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: The InCHIANTI study. Biol Psychiatry 2009; 65: 973-978.
16. Comijs HC, Van Marwijk HW, Van Der Mast RC,. The Netherlands Study of Depression in Older Persons (NESDO): A prospective cohort study. BMC Res Notes 2011; 4: 524.
17. Wittchen HU, Robins LN, Cottler LB, et al., Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br J Psychiatry 1991; 159: 645-653.
18. Radloff L,. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
19. Craig CL, Marshall AL, Sjoström M, et al., International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35: 1381-1395.
20. Kriegsman DM, Penninx BW, van Eijk JT, et al., Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 1996; 49: 1407-1417.
21. Rush AJ, Gullion CM, Basco MR, et al., The Inventory of Depressive Symptomatology (IDS): Psychometric properties. Psychol Med 1996; 26: 477-486.
22. Cotteleer C, Gardebroek K, Vrolijk HCJ, Dol W,. Opfriscursus Statistiek. Den Haag, the Netherlands: LEI, 2003.
23. Costello AB, Osborne JW,. Exploratory factor analysis: Four recommendations for getting the most from your analysis. Pract Assesst Res Eval 2005; 10: 1-9.
24. Fielding RA, Vellas B, Evans WJ, et al., Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 2011; 12: 249-256.
25. Evans W,. Functional and metabolic consequences of sarcopenia. J Nutr 1997; 127: 998S-1003S.
26. Naudé PJ, den Boer JA, Comijs HC, et al., Sex-specific associations between neutrophil gelatinase-associated lipocalin (NGAL) and cognitive domains in late-life depression. Psychoneuroendocrinology 2014; 48: 169-177.
27. Ford DE, Erlinger TP,. Depression and C-reactive protein in US adults: Data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2004; 164: 1010-1014.
28. Dowlati Y, Herrmann N, Swardfager W, et al., A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446-457.
29. Schiepers OJ, Wichers MC, Maes M,. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 201-217.
30. Visser M, Pahor M, Taaffe DR, et al., Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J Gerontol A Biol Sci Med Sci 2002; 57A: M326-M332.